Market by Product Type, Application, and Country Outlook | Forecast 2022-2028
A study by Triton on Europe’s medical enzymes market shows that
the market will develop with a CAGR of 6.12% in the forecast duration 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market include:
• Spain
• France
• Germany
• Italy
• The
United Kingdom
• Rest
of Europe
The
increase in research & development activities and the rising funding for
research are largely driving the growth of the medical enzymes market in the
region. According to data from the NCBI, a rise in research publications and
patents has been observed due to the promising therapeutic potential of medical
enzymes, as they are used for treating cancer and cardiovascular diseases.
There
were nearly 375,400 cancer cases reported in the United Kingdom during 2016-2018,
and this number is expected to rise further. Also, cardiovascular disease is
one of the major causes for mortality in the country. The growing health issues
among people are one of the major reasons driving the demand for medical
enzymes. This is expected to foster the market growth in the UK over the coming
years.
The
medical enzymes market in France is anticipated to be on an upward trend. The
prevalence of cancer and CVDs is growing, and these diseases are some of the
leading causes of death among the people in the country. Additionally, smoking
and alcohol consumption are also two major factors responsible for death. Thus,
owing to the application of enzymes for the treatment of such diseases, the
medical enzymes market is expected to be on a growth path.
Enzyme
biosensors are used as analytical tools for diagnosing various diseases. The increasing
demand for diagnosing and monitoring a number of diseases due to routine
examination of clinical samples & other associated tests is anticipated to support
the growth of the diagnostic tools segment during the forecast period.
The report assesses the market
based on product type and application. Here,
the application segment comprises diagnostic tools, disease treatment,
biomedical research, and other applications.
The notable companies in the medical
enzymes market include Sanofi SA, Novozymes, Amano Enzyme, BASF SE, DuPont, BBI
Solutions, Roche Holding AG, and Brain Biotech AG.
BBISolutions
is a leading name in the field of enzymes and offers products and services to
the diagnostic and life sciences industries. The portfolio of the company includes
enzymes, antigens, antibodies, serum & plasma, gold reagents, as well as
cell culture reagents’ development. The enzymes produced by BBI are used in
diagnostic tests like glucose oxidase for monitoring blood glucose levels.
Founded in 1986, the UK-based company is headquartered in Crumlin, County
Antrim.
Key deliverables of the report:
· Market CAGR during the forecasting years 2022-2028
· Detailed data highlighting key insights, industry components, and market strategies
· Comprehensive information and estimation of the medical enzymes market revenue growth in Europe and its influence on the parent market
· In-depth study of forthcoming trends in consumer behavioral patterns
· A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model
· A wide-ranging study of factors that will challenge the Europe medical
enzymes market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize
this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
MEDICAL ENZYMES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL ENZYMES MARKET
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN ENZYME ENGINEERING
2.2.2. INCREASED
DEMAND IN THE PHARMACEUTICAL SECTOR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. PRICE
2.4.2. QUALITY
2.4.3. USAGE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.7.1. RESEARCH
AND DEVELOPMENT
2.7.2. OPERATIONS
2.7.3. OUTBOUND
LOGISTICS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES & DEVELOPMENTS
2.9.3. PARTNERSHIPS
& AGREEMENTS
2.9.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. RISING
INVESTMENTS IN RESEARCH AND DEVELOPMENT
2.10.2. RISING
AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES
2.10.3. INCREASING
APPLICATION IN THE PHARMACEUTICAL INDUSTRY
2.11. MARKET
CHALLENGES
2.11.1. STRICT
REGULATIONS
2.11.2. SAFETY
CONCERNS WHILE HANDLING ENZYMES
2.12. MARKET
OPPORTUNITIES
2.12.1. RISING
HEALTH ISSUES AND GROWING AWARENESS
2.12.2. RISING
DEMAND FOR SPECIALTY ENZYMES
3. EUROPE
MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE
3.1. HYDROLASE
3.1.1. HYALURONIDASE
3.1.2. LYSOZYMES
3.1.3. OTHER
HYDROLASES ENZYMES
3.2. THROMBOLYTIC
ENZYME
3.2.1. STREPTOKINASE
3.2.2. UROKINASE
3.2.3. OTHER
THROMBOLYTIC ENZYMES
3.3. DIGESTIVE
ENZYME
3.3.1. LACTASE
3.3.2. L-ASPARAGINASE
3.3.3. OTHER
DIGESTIVE ENZYMES
3.4. ENDONUCLEASE
3.4.1. BENZONASE
3.4.2. OTHER
ENDONUCLEASES
4. EUROPE
MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION
4.1. DISEASE
TREATMENT
4.2. DIAGNOSTIC
TOOLS
4.3. BIOMEDICAL
RESEARCH
4.4. OTHER
APPLICATIONS
5. EUROPE
MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK
5.1. UNITED
KINGDOM
5.2. GERMANY
5.3. FRANCE
5.4. SPAIN
5.5. ITALY
5.6. REST
OF EUROPE
6. COMPETITIVE
LANDSCAPE
6.1. BASF
SE
6.2. DUPONT
6.3. ROCHE
HOLDING AG
6.4. NOVOZYMES
6.5. DSM
6.6. SANOFI
SA
6.7. CODEXIS
6.8. ADVANCED
ENZYMES
6.9. AMANO
ENZYME
6.10. BBI
SOLUTIONS
6.11. THERMOFISHER
SCIENTIFIC INC
6.12. CPC
BIOTECH
6.13. NOVUS
6.14. BRAIN
BIOTECH AG
6.15. SEKISUI
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE MEDICAL
ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: APPLICATIONS
OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY
TABLE 3: VENDOR
SCORECARD
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 8: LIST OF
BUSINESS EXPANSIONS & DIVESTITURES
TABLE 9: MEDICAL
APPLICATION OF VARIOUS ENZYMES
TABLE 10: EUROPE
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 11: EUROPE MEDICAL
ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 12: EUROPE
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 13: EUROPE
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 14: EUROPE
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
TABLE 15: EUROPE
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 16: EUROPE
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: EUROPE
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 5: EUROPE
MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)
FIGURE 7: EUROPE
MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)
FIGURE 8: EUROPE
MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE
MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)
FIGURE 12: EUROPE
MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE
MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)
FIGURE 14: EUROPE
MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 16: EUROPE
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)
FIGURE 17: EUROPE
MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE
MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)
FIGURE 19: EUROPE
MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 20: EUROPE
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: EUROPE
MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)
FIGURE 22: EUROPE
MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)
FIGURE 23: EUROPE
MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)
FIGURE 24: EUROPE
MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 25: EUROPE
MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)
FIGURE 26: EUROPE
MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)
FIGURE 27: EUROPE
MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)
FIGURE 28: EUROPE
MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 29: EUROPE
MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 30: UNITED
KINGDOM MEDICAL ENZYMES MARKET, 2022-2028 (IN $ MILLION)
FIGURE 31: GERMANY
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: FRANCE
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: SPAIN MEDICAL
ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: ITALY
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: REST OF
EUROPE MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)